HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Leung, W. C. Articles by Tang, M. H. Y. Search for Related Content PubMed PubMed Citation Articles by Leung, W. C. Articles by Tang, M. H. Y.

Can Amnio–Polymerase Chain Reaction Alone Replace Conventional Cytogenetic Study for Women With Positive Biochemical Screening for Fetal Down Syndrome?

From the Department of Obstetrics and Gynaecology, Queen Mary Hospital, University of Hong Kong; and Prenatal Diagnostic and Counselling Department, Tsan Yuk Hospital, Hong Kong, People’s Republic of China.

Address reprint requests to: Wing Cheong Leung, MRCOG, Senior Medical Officer, Department of Obstetrics & Gynaecology, Queen Mary Hospital, 102, Pokfulam Road, Hong Kong, People’s Republic of China; E-mail: leungwc65{at}hotmail.com.

OBJECTIVE: To determine whether amnio–polymerase chain reaction (amnio-PCR) can replace conventional cytogenetic study for confirming the karyotype of fetuses in women with positive biochemical screening for fetal Down syndrome.

METHOD: To check the accuracy of this technique in our laboratory, we first compared the amnio-PCR results with those of conventional cytogenetic study in 235 patients referred from June 1999 to December 2001 for prenatal diagnosis in a referral center in Hong Kong. We then reviewed the results of 1526 amniotic fluid cultures performed for positive fetal Down syndrome screening between January 1997 and December 2001 and classified them as detectable or not detectable by amnio-PCR, using the assumption that we had replaced conventional cytogenetic study with amnio-PCR.

RESULTS: The 235 amnio-PCR results were all informative, without a false-positive or false-negative result. Of the 1526 cases with positive fetal Down syndrome screening and no ultrasound abnormalities, only two cases of sex chromosome abnormalities and two cases of marker chromosomes would have been missed if conventional cytogenetic study had been replaced by amnio-PCR.

CONCLUSION: Amnio-PCR can be an alternative to conventional cytogenetic study for women with positive biochemical screening for fetal Down syndrome and no demonstrable fetal structural abnormality.

This article has been cited by other articles:

				K.Y. Tse, W.C. Leung, K.Y. Leung, C.P. Lee, L.K.L. Ng, E.T. Lau, V. Chan, and M.H.Y. Tang Full karyotyping, rapid aneuploidy diagnosis or both when invasive prenatal testing is performed for diagnosis of thalassaemia? Mol. Hum. Reprod., January 1, 2006; 12(1): 55 - 59. [Abstract] [Full Text] [PDF]

				C. M. Ogilvie, C. Donaghue, S. P. Fox, Z. Docherty, and K. Mann Rapid Prenatal Diagnosis of Aneuploidy Using Quantitative Fluorescence-PCR (QF-PCR) J. Histochem. Cytochem., March 1, 2005; 53(3): 285 - 288. [Abstract] [Full Text] [PDF]

				U. Nicolini, F. Lalatta, F. Natacci, C. Curcio, and T.-H. Bui The introduction of QF-PCR in prenatal diagnosis of fetal aneuploidies: time for reconsideration Hum. Reprod. Update, November 1, 2004; 10(6): 541 - 548. [Abstract] [Full Text] [PDF]

				Amnio-PCR Not As Accurate As Karyotypic Analysis Journal Watch Women's Health, June 17, 2003; 2003(617): 5 - 5. [Full Text]

				K. D. Wenstrom Aneuploidy Screening: The Changing Scene Obstet. Gynecol., May 1, 2003; 101(5): 840 - 842. [Full Text] [PDF]